Marzetti
MZTI
100.43
+0.23
+0.23%
Marzetti
US · MZTI
#2591 by market cap
Listed 1970
100.43
+0.23
+0.23%
Live - 5344 symbols - heartbeat 32s ago
· 2026-10-08 07:18
Pre-market
99.05
-1.37%
After-hours
100.43
0.00%
- Market cap
- 2.74B
- P/E (TTM)i
- 14.39
- P/Bi
- 2.60
- EPSi
- 6.98
- Div yieldi
- 3.93%
- 52W posi
- 5%
Reader sentiment
Are you bullish or bearish on MZTI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 6.23, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1.08% YoY
Margins
- Gross margin
- 24.73%
- Operating margin
- 11.54%
- Net margin
- 9.91%
Key ratios & quality
- Enterprise valuei
- 2.93B
- PEG ratioi
- 0.72
- Altman Z-Scorei
- 6.23
PEG uses trailing P/E against the 3-year net income growth rate (19.86%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.31B | 1.33B | 1.47B | 1.68B | 1.82B | 1.87B | 1.91B | 1.93B |
| Gross profit | 326.20M | 358.04M | 386.72M | 355.72M | 388.57M | 432.30M | 455.65M | 477.29M |
| Selling & admin expenses | 149.81M | 180.95M | 205.36M | 212.10M | 222.09M | 218.07M | 230.23M | 254.60M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 176.39M | 177.09M | 181.36M | 143.62M | 166.48M | 214.24M | 225.42M | 222.69M |
| Pretax profit | 195.54M | 179.08M | 185.75M | 112.39M | 143.30M | 205.52M | 213.46M | 241.97M |
| Tax | 44.99M | 42.09M | 43.41M | 22.80M | 32.01M | 46.90M | 46.12M | 50.36M |
| Net profit | 150.55M | 136.98M | 142.33M | 89.59M | 111.29M | 158.61M | 167.35M | 191.61M |
| Basic EPS | 5 | 5 | 5 | 3 | 4 | 6 | 6 | 7 |
| Diluted EPS | 5.46 | 4.97 | 5.16 | 3.25 | 4.04 | 5.76 | 6.07 | 6.98 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 457.84M | 475.43M | 493.47M | 517.95M | 453.37M | 465.03M |
| Gross profit | 105.96M | 106.09M | 118.82M | 137.26M | 107.22M | 113.99M |
| Selling & admin expenses | 56.09M | 62.08M | 58.42M | 60.41M | 61.44M | 74.34M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 49.88M | 44.02M | 60.40M | 76.85M | 45.78M | 39.66M |
| Pretax profit | 51.84M | 40.51M | 60.79M | 76.34M | 48.32M | 56.52M |
| Tax | 10.71M | 7.98M | 13.61M | 17.26M | 11.26M | 8.23M |
| Net profit | 41.12M | 32.53M | 47.18M | 59.08M | 37.06M | 48.29M |
| Basic EPS | 1 | 1 | 2 | 2 | 1 | 2 |
| Diluted EPS | 1.49 | 1.18 | 1.71 | 2.15 | 1.35 | 1.76 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 368.57M | 385.61M | 423.48M | 351.78M | 374.46M | 443.99M | 443.63M | 360.96M |
| Cash & ST investments | 196.29M | 198.27M | 188.06M | 60.28M | 88.47M | 163.44M | 161.48M | 25.10M |
| Inventory | 86.07M | 85.05M | 121.88M | 144.70M | 158.27M | 173.25M | 169.30M | 205.06M |
| Total assets | 905.40M | 993.35M | 1.10B | 1.09B | 1.11B | 1.21B | 1.27B | 1.61B |
| Total current liabilities | 119.71M | 126.26M | 173.92M | 165.59M | 168.75M | 183.97M | 186.29M | 231.54M |
| Short-term debt | -- | 7.34M | 9.38M | 11.42M | 10.77M | 12.33M | 11.72M | 21.31M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | 189.28M |
| Total liabilities | 178,526,000.00 | 210,053,000.00 | 258,138,000.00 | 245,687,000.00 | 250,727,000.00 | 281,159,000.00 | 276,229,000.00 | 551,870,000.00 |
| Total equity | 726.87M | 783.30M | 843.15M | 844.69M | 862.27M | 925.77M | 998.50M | 1.05B |
| Retained earnings | 1.36B | 1.42B | 1.48B | 1.49B | 1.50B | 1.56B | 1.63B | 1.71B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 439.66M | 443.63M | 499.33M | 491.41M | 513.93M | 360.96M |
| Cash & ST investments | 124.56M | 161.48M | 182.15M | 201.58M | 218.45M | 25.10M |
| Inventory | 191.15M | 169.30M | 174.03M | 162.58M | 175.26M | 205.06M |
| Total assets | 1.28B | 1.27B | 1.34B | 1.33B | 1.36B | 1.61B |
| Total current liabilities | 186.38M | 186.29M | 201.47M | 180.66M | 198.86M | 231.54M |
| Short-term debt | -- | 11.72M | -- | -- | -- | 21.31M |
| Long-term debt | -- | -- | -- | -- | -- | 189.28M |
| Total liabilities | 280,364,000.00 | 276,229,000.00 | 319,693,000.00 | 296,032,000.00 | 311,259,000.00 | 551,870,000.00 |
| Total equity | 996.25M | 998.50M | 1.02B | 1.03B | 1.04B | 1.05B |
| Retained earnings | 1.62B | 1.63B | 1.65B | 1.68B | 1.69B | 1.71B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 197.60M | 170.77M | 174.19M | 101.81M | 225.90M | 251.55M | 261.50M | 283.82M |
| Depreciation & amortization | 31.85M | 37.96M | 44.51M | 45.88M | 51.21M | 55.90M | 62.17M | 71.45M |
| Free cash flow | 126.72M | 88.13M | 86.32M | -30.16M | 135.72M | 183.98M | 203.50M | 206.14M |
| Dividends paid | -70.11M | -75.64M | -81.23M | -86.76M | -92.37M | -97.93M | -103.50M | -108.76M |
| Stock buybacks / issuance | -7.41M | -5.46M | -8.53M | -7.56M | -9.20M | -7.65M | -7.99M | -36.27M |
| Ending cash balance | 196.29M | 198.27M | 188.06M | 60.28M | 88.47M | 163.44M | 161.48M | 25.10M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 45.81M | 88.18M | 69.51M | 88.62M | 70.53M | 55.16M |
| Depreciation & amortization | 15.65M | 17.11M | 16.71M | 17.54M | 17.54M | 19.66M |
| Free cash flow | 30.75M | 73.89M | 53.88M | 70.95M | 49.26M | 32.05M |
| Dividends paid | -26.18M | -26.20M | -26.32M | -27.59M | -27.48M | -27.37M |
| Stock buybacks / issuance | -76.00K | -6.47M | -1.14M | -20.05M | -16.00K | -15.06M |
| Ending cash balance | 124.56M | 161.48M | 182.15M | 201.58M | 218.45M | 25.10M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 21.79 | 18.10 | 17.47 | 10.59 | 13.01 | 17.70 | 17.35 | 18.64 |
| ROA %i | 17.58 | 14.40 | 13.56 | 8.15 | 10.08 | 13.64 | 13.45 | 13.28 |
| ROIC %i | 21.79 | 17.53 | 16.87 | 10.17 | 12.52 | 16.87 | 16.38 | 16.32 |
| 5-year avg ROE %i | 21.08 | 21.05 | 20.10 | 17.99 | 16.19 | 15.37 | 15.22 | 15.46 |
| EBIT margin %i | 13.49 | 13.27 | 12.36 | 8.57 | 9.13 | 11.45 | 11.81 | 12.63 |
| FCF / sales %i | 9.69 | 6.60 | 5.88 | -- | 7.45 | 9.83 | 10.66 | 10.68 |
| Current ratioi | 3.08 | 3.05 | 2.43 | 2.12 | 2.22 | 2.41 | 2.38 | 1.56 |
| Quick ratioi | 2.27 | 2.26 | 1.64 | 1.18 | 1.21 | 1.41 | 1.38 | 0.56 |
| Debt / assetsi | 0.00 | 2.70 | 3.02 | 3.32 | 2.69 | 4.78 | 4.36 | 15.81 |
| LT debt / equityi | -- | 2.49 | 2.83 | 2.94 | 2.23 | 4.90 | 4.39 | 22.07 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | 138.25 |
| Revenue CAGR (3Y) %i | 3.16 | 3.55 | 6.26 | 8.63 | 10.95 | 8.46 | 4.43 | 1.93 |
| Net income CAGR (3Y) %i | 7.33 | 5.91 | 1.70 | -15.89 | -6.69 | 3.68 | 23.16 | 19.86 |
| FCF CAGR (3Y) %i | -0.65 | -9.62 | -12.69 | -- | 15.48 | 28.69 | -- | 14.95 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 17.73 | 17.35 | 17.25 | 17.84 | 17.19 | 18.64 |
| ROA %i | 13.82 | 13.45 | 13.26 | 13.98 | 13.33 | 13.28 |
| ROIC %i | 17.24 | 16.38 | 16.55 | 17.15 | 16.55 | 16.32 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 11.97 | 11.81 | 11.88 | 11.89 | 11.70 | 12.63 |
| FCF / sales %i | 7.85 | 10.66 | 13.18 | 11.80 | 12.78 | 10.68 |
| Current ratioi | 2.36 | 2.38 | 2.48 | 2.72 | 2.58 | 1.56 |
| Quick ratioi | 1.24 | 1.38 | 1.41 | 1.69 | 1.59 | 0.56 |
| Debt / assetsi | 3.28 | 4.36 | 3.07 | 2.92 | 2.74 | 15.81 |
| LT debt / equityi | 4.20 | 4.39 | 4.03 | 3.75 | 3.56 | 22.07 |
| Interest coveragei | -- | -- | -- | -- | -- | 138.25 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Retail is the largest reported line at 51.96% of revenue, across 2 reported segments.
- Foodservice follows at 48.04%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Retail51.96%
Foodservice48.04%
Region
Domestic100.00%
Quote time 2026-10-08 07:18:22 · For reference only, not investment advice and not tailored to your situation.